Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tropapride

Known as: exo-2,3-dimethoxy-N-(8-(phenylmethyl)-8-azabicyclo(3.2.1)oct-3-yl)benzamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Neuroleptic drugs have been suggested to act as inverse agonists at the dopamine D2 receptor, but no link between therapeutic… Expand
Is this relevant?
2003
2003
Abstract Neuroleptic drugs have been suggested to act as inverse agonists at the dopamine D2 receptor. Nevertheless, the capacity… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2001
2001
Antipsychotic drugs comprise a wide range of structurally diverse compounds and are considered to be antagonists at dopamine D2… Expand
Is this relevant?
2001
2001
Abstract. Real-time analysis of dopamine:antagonist interactions at the recombinant D2short receptor was performed by measuring… Expand
  • table 1
Is this relevant?
1999
1999
Rationale: Combining neuroleptics with 5-HT1A ligands is thought to improve the preclinical profile of neuroleptics and may be of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1992
1992
Tropapride, (exo)-2,3-dimethoxy-N-[8-(phenylmethyl)-8- azabicyclo[3.2.1]oct-3-yl]benzamide hydrochloride, has been labeled with… Expand
Is this relevant?
1989
1989
SummaryMolecular graphic design coupled with PCILO and crystallographic results have been used to investigate the three… Expand
Is this relevant?
1984
1984
The topography of the central dopaminergic receptor (D-2) has been studied using some analogues of tropapride, a new benzamide… Expand
Is this relevant?
1984
1984
Localization of tropapride and 1-sulpiride in the pituitary gland of the rat has been studied. A comparison of the ratio of total… Expand
Is this relevant?